that I would dedicate hours to exposing as dangerous and pointless, it would be Abilify:
(from Furious Seasons) A recent conference call with financial analysts by executives with Bristol-Myers Squibb, makers of Abilify--the antipsychotic that will cure your non-psychotic issues--is revealing. Over 10 percent of Americans now take an atypical antipsychotic for depression, according to the company. Much of that prescribing has got to be off-label as Abilify is the only approved antipsychotic for the condition, all of which makes me damn suspicious of how Seroquel's bipolar depression approval in 2006 may have been turned into a proxy approval for major depression.
(from Furious Seasons) A recent conference call with financial analysts by executives with Bristol-Myers Squibb, makers of Abilify--the antipsychotic that will cure your non-psychotic issues--is revealing. Over 10 percent of Americans now take an atypical antipsychotic for depression, according to the company. Much of that prescribing has got to be off-label as Abilify is the only approved antipsychotic for the condition, all of which makes me damn suspicious of how Seroquel's bipolar depression approval in 2006 may have been turned into a proxy approval for major depression.
Forget about Prozac Nation, this is Atypical Nation. Think I'm joking? Antipsychotics are now the top revenue producing class of drugs, topping even statins.
This is so grim, so cynical...even as real progress is being made on the disclosure and bribe front in the journals and medical schools, the big drug makers are pushing harder and harder.
Keep your kids off of this drug.
But in the interest of clarity, I am going to ring up a psychiatrist I know and trust and get his take on it.
No comments:
Post a Comment